Preliminary studies suggest that COVID-19 causes long-term lung damage, even in young, otherwise healthy people who did not need to go to hospital or the ICU. We seek to know how common long-term lung damage after COVID-19 is, who is most affected by it and what the effects of this damage are on other important aspects of people's lives. We plan to study a large sample of people with a history of COVID-19 infection from across Canada-some who needed hospitalization but most who did not. Through online questionnaires, we will determine their respiratory symptoms, quality of life and medical history. Then we will invite them to one of our thirteen Canadian testing centres to have special, thorough breathing tests. We hypothesize that COVID-19 leaves a significant proportion of people with measurable respiratory impairment. The information we learn about the effect of COVID-19 on the lungs will help patients and health care providers manage it better. It will also reveal how different COVID-19 variants affect the lungs. We will use this new knowledge to write a formal guide on what respiratory monitoring and testing should be done after COVID-19 infection. This will ensure that people affected by COVID-19 get the care they need to maintain their lung health.
We will prospectively recruit a representative, random sample of adult (age ≥ 18), community-dwelling patients, who have had a positive PCR test for COVID-19 infection and symptomatic infection five to 12 months previously. This cross-sectional, observational study will have two phases: 1. Screening: Screening for eligibility 2. Observation Period: 1. Online / telephone visit: All participants will complete a series of questionnaires (either online or by phone with the assistance of research personnel). In the questionnaires they will be asked about respiratory symptoms (the primary outcome), baseline participant data, burden of respiratory symptoms, overall quality of life, mental health issues as well as physical and psychological trauma from COVID-19. 2. In-person visit: All participants will complete pulmonary function testing including oscillometry. The study of COVID-19 infection and its long-term effects is constantly evolving. Over the course of this research study, new knowledge may become available that may lead to changes in the study's outcome measures.
Study Type
OBSERVATIONAL
Enrollment
450
St. Paul's Hospital
Vancouver, British Columbia, Canada
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Kingston Health Sciences Centre
Kingston, Ontario, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Institut Universitaire de Cardiologie et de Pneumologie de Québec
Québec, Canada
To determine the prevalence of respiratory post-acute sequelae of SARS-CoV-2 (PASC) and PASC
Time frame: At five-12 months post positive PCR test for SARS-CoV-2 infection
To determine risk factors for respiratory PASC
Time frame: At five-12 months post positive PCR test for SARS-CoV-2 infection
To determine the spectrum of severity of respiratory PASC
Time frame: At five-12 months post positive PCR test for SARS-CoV-2 infection
To determine objective physiologic characteristics of respiratory PASC
Time frame: At five-12 months post positive PCR test for SARS-CoV-2 infection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.